CO4750643A1
(es)
*
|
1997-06-13 |
1999-03-31 |
Lilly Co Eli |
Formulacion estable de la insulina que contiene l-arginina y protamina
|
US6211144B1
(en)
*
|
1998-10-16 |
2001-04-03 |
Novo Nordisk A/S |
Stable concentrated insulin preparations for pulmonary delivery
|
JP3971108B2
(ja)
|
1999-01-06 |
2007-09-05 |
ジェネンテック・インコーポレーテッド |
インシュリン様成長因子(igf)i突然変異体
|
WO2000040612A1
(en)
|
1999-01-06 |
2000-07-13 |
Genentech, Inc. |
Insulin-like growth factor (igf) i mutant variants
|
JP4360758B2
(ja)
|
1999-04-08 |
2009-11-11 |
ジェネンテック・インコーポレーテッド |
逆の電荷のポリペプチド類をベースにした組成物
|
US20040220103A1
(en)
*
|
1999-04-19 |
2004-11-04 |
Immunex Corporation |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
US6746853B1
(en)
|
1999-05-19 |
2004-06-08 |
Xencor, Inc. |
Proteins with insulin-like activity useful in the treatment of diabetes
|
US7169889B1
(en)
*
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
US7022674B2
(en)
*
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
US6734162B2
(en)
|
2000-01-24 |
2004-05-11 |
Minimed Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
AU2001254621A1
(en)
*
|
2000-05-05 |
2001-11-20 |
K.U. Leuven R And D |
Critical illness neuropathy
|
AU2001263215A1
(en)
|
2000-05-16 |
2001-11-26 |
Genentech Inc. |
Method for treating cartilage disorders
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6852694B2
(en)
|
2001-02-21 |
2005-02-08 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
DE10114178A1
(de)
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
US6835802B2
(en)
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
*
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
DK1412384T3
(da)
|
2001-06-28 |
2008-04-28 |
Novo Nordisk As |
Stabil formulering af modificeret GLP-1
|
US6737401B2
(en)
*
|
2001-06-28 |
2004-05-18 |
Metronic Minimed, Inc. |
Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US20030068361A1
(en)
*
|
2001-10-09 |
2003-04-10 |
Rimona Margalit |
Liposome-encapsulated insulin formulations
|
US20030199445A1
(en)
*
|
2002-02-07 |
2003-10-23 |
Knudsen Lotte Bjerre |
Use of GLP-1 compound for treatment of critically ill patients
|
AU2003236201A1
(en)
*
|
2002-05-07 |
2003-11-11 |
Novo Nordisk A/S |
Soluble formulations comprising monomeric insulin and acylated insulin
|
DE10227232A1
(de)
*
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
KR101123113B1
(ko)
*
|
2002-07-29 |
2012-03-15 |
쎄라피콘 에스.알.엘. |
코 펩티드 약학 제형
|
ITMI20021684A1
(it)
*
|
2002-07-29 |
2004-01-29 |
Therapicon Srl |
Composizione farmaceutica di peptide nasale
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
JP2007524592A
(ja)
|
2003-06-03 |
2007-08-30 |
ノボ・ノルデイスク・エー/エス |
安定化された薬学的ペプチド組成物
|
HUE038395T2
(hu)
|
2003-11-20 |
2018-10-29 |
Novo Nordisk As |
Propilén-glikol tartalmú peptidkészítmények, amelyek elõállításra és injekciós eszközökben történõ alkalmazásra optimálisak
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
PL1773878T3
(pl)
|
2004-07-19 |
2015-07-31 |
Biocon Ltd |
Koniugaty insulina-oligomer, ich formulacje i zastosowania
|
CA2576030A1
(en)
*
|
2004-08-09 |
2006-02-23 |
Alios Biopharma Inc. |
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
MX2007005521A
(es)
|
2004-11-12 |
2007-05-18 |
Novo Nordisk As |
Formulaciones estables de peptidos insulinotropicos.
|
US8263551B2
(en)
|
2004-11-22 |
2012-09-11 |
Novo Nordisk A/S |
Soluble, stable insulin-containing formulations with a protamine salt
|
PL1830888T3
(pl)
|
2004-12-27 |
2015-12-31 |
Silence Therapeutics Gmbh |
Kompleksy lipidowe pokryte PEG i ich wykorzystanie
|
WO2006093222A1
(ja)
*
|
2005-03-02 |
2006-09-08 |
Ajinomoto Co., Inc. |
インスリンの多量体形成阻害剤
|
EP1888118B1
(en)
*
|
2005-05-25 |
2016-08-17 |
Novo Nordisk A/S |
Polypeptide formulations stabilized with ethylenediamine
|
EP1888117A1
(en)
*
|
2005-05-25 |
2008-02-20 |
Novo Nordisk A/S |
Stabilized polypeptide formulations
|
DE102005035891A1
(de)
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
KR20080064171A
(ko)
*
|
2005-10-20 |
2008-07-08 |
나스텍 파마수티컬 컴퍼니 인코포레이티드 |
속효성 인슐린의 비강내 투여
|
PL1969004T3
(pl)
|
2005-12-28 |
2012-01-31 |
Novo Nordisk As |
Kompozycje zawierające acylowaną insulinę i cynk oraz sposób wytwarzania tych kompozycji
|
US8927015B2
(en)
*
|
2006-04-12 |
2015-01-06 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
JP2009534342A
(ja)
*
|
2006-04-20 |
2009-09-24 |
サイレンス・セラピューティクス・アーゲー |
血管内皮に特異的に送達するためのリポプレックス処方剤
|
CN101437823B
(zh)
|
2006-05-04 |
2014-12-10 |
勃林格殷格翰国际有限公司 |
多晶型
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
WO2007135117A2
(en)
*
|
2006-05-24 |
2007-11-29 |
Novo Nordisk A/S |
Soluble, stable insulin-containing formulations
|
US9023793B2
(en)
*
|
2006-09-29 |
2015-05-05 |
Retrophin, Inc. |
Intranasal carbetocin formulations and methods for the treatment of autism
|
GB0700523D0
(en)
*
|
2007-01-11 |
2007-02-21 |
Insense Ltd |
The Stabilisation Of Proteins
|
US8114428B2
(en)
*
|
2007-03-08 |
2012-02-14 |
Sbf Synthetic Bone Factory Gmbh |
Methods for manufacturing a composition for treating bone and/or cartilage defects
|
WO2008118387A2
(en)
*
|
2007-03-23 |
2008-10-02 |
Wayne State University |
Erythrocyte atp-release modulators
|
US20080260820A1
(en)
*
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
US9241908B2
(en)
*
|
2007-10-16 |
2016-01-26 |
Biocon Limited |
Orally administrable solid pharmaceutical composition and a process thereof
|
US8986253B2
(en)
|
2008-01-25 |
2015-03-24 |
Tandem Diabetes Care, Inc. |
Two chamber pumps and related methods
|
WO2009115469A1
(en)
|
2008-03-18 |
2009-09-24 |
Novo Nordisk A/S |
Protease stabilized, acylated insulin analogues
|
AR071175A1
(es)
|
2008-04-03 |
2010-06-02 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
|
TWI394580B
(zh)
|
2008-04-28 |
2013-05-01 |
Halozyme Inc |
超快起作用胰島素組成物
|
CN102066401A
(zh)
|
2008-05-01 |
2011-05-18 |
艾瑞克有限公司 |
蛋白质制品
|
TWI451876B
(zh)
*
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
EP2328607A1
(en)
|
2008-07-16 |
2011-06-08 |
Arecor Limited |
Stable formulation of a therapeutic protein
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
KR20200118243A
(ko)
|
2008-08-06 |
2020-10-14 |
베링거 인겔하임 인터내셔날 게엠베하 |
메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
|
ES2477552T3
(es)
|
2008-09-08 |
2014-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Moduladores de la actividad de la aldehidodeshidrogenasa y métodos de uso de los mismos
|
US8513264B2
(en)
|
2008-09-10 |
2013-08-20 |
Boehringer Ingelheim International Gmbh |
Combination therapy for the treatment of diabetes and related conditions
|
US8408421B2
(en)
|
2008-09-16 |
2013-04-02 |
Tandem Diabetes Care, Inc. |
Flow regulating stopcocks and related methods
|
CA2737461A1
(en)
|
2008-09-19 |
2010-03-25 |
Tandem Diabetes Care, Inc. |
Solute concentration measurement device and related methods
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
RS59913B1
(sr)
|
2008-10-17 |
2020-03-31 |
Sanofi Aventis Deutschland |
Kombinacija insulina i glp-1-agonista
|
JP2012506856A
(ja)
|
2008-10-28 |
2012-03-22 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
アルデヒドデヒドロゲナーゼのモジュレーターおよびその使用方法
|
US9603904B2
(en)
|
2008-10-30 |
2017-03-28 |
Novo Nordisk A/S |
Treating diabetes melitus using insulin injections with less than daily injection frequency
|
CA2745037C
(en)
|
2008-12-23 |
2020-06-23 |
Boehringer Ingelheim International Gmbh |
Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8(3-(r)-amino-piperidin-1-yl)-xanthine
|
AR074990A1
(es)
|
2009-01-07 |
2011-03-02 |
Boehringer Ingelheim Int |
Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
|
CA2750223A1
(en)
|
2009-01-28 |
2010-08-05 |
Smartcells, Inc. |
Exogenously triggered controlled release materials and uses thereof
|
JP2012516340A
(ja)
|
2009-01-28 |
2012-07-19 |
スマートセルズ・インコーポレイテツド |
合成コンジュゲートおよびその使用
|
MX2011007929A
(es)
|
2009-01-28 |
2011-08-17 |
Smartcells Inc |
Sistemas basados en conjugados para entrega farmacologica controlada.
|
RU2011135730A
(ru)
|
2009-01-28 |
2013-03-10 |
Смартселлз, Инк. |
Кристаллические инсулин-коньюгаты
|
WO2010092218A2
(es)
|
2009-02-12 |
2010-08-19 |
Proyecto De Biomedicina Cima, S.L. |
Uso de la cardiotrofina-1 para el tratamiento de enfermedades metabólicas
|
EP2401587A2
(en)
|
2009-02-27 |
2012-01-04 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
US9250106B2
(en)
|
2009-02-27 |
2016-02-02 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
EP2408808A4
(en)
|
2009-03-20 |
2015-05-06 |
Smartcells Inc |
TERMINAL-FUNCTIONALIZED CONJUGATES AND THEIR USE
|
WO2010107520A1
(en)
|
2009-03-20 |
2010-09-23 |
Smartcells, Inc. |
Soluble non-depot insulin conjugates and uses thereof
|
EP2340033B1
(en)
*
|
2009-06-26 |
2013-10-09 |
Novo Nordisk A/S |
PREPARATION COMPRISING INSULIN, NICOTINAMIDE AND Arginine
|
US8926561B2
(en)
|
2009-07-30 |
2015-01-06 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
KR101972301B1
(ko)
|
2009-11-13 |
2019-04-25 |
사노피-아벤티스 도이칠란트 게엠베하 |
Glp-1 작용제, 인슐린 및 메티오닌을 포함하는 약제학적 조성물
|
BR112012011403B8
(pt)
|
2009-11-13 |
2021-05-25 |
Sanofi Aventis Deutschland |
composição farmacêutica líquida compreendendo um agonista glp-1 e metionina e uso da mesma
|
US9457029B2
(en)
|
2009-11-27 |
2016-10-04 |
Boehringer Ingelheim International Gmbh |
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
|
CN101912600B
(zh)
*
|
2010-01-11 |
2014-01-29 |
杨国汉 |
改善胰岛素在溶液中稳定性的方法
|
BR112012028136A2
(pt)
|
2010-05-05 |
2016-08-09 |
Boehringer Ingelheim Int |
terapia de combinaçao
|
AU2011202239C1
(en)
|
2010-05-19 |
2017-03-16 |
Sanofi |
Long-acting formulations of insulins
|
KR20130093012A
(ko)
|
2010-06-24 |
2013-08-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
당뇨병 요법
|
US9074015B2
(en)
|
2010-07-28 |
2015-07-07 |
Smartcells, Inc. |
Recombinantly expressed insulin polypeptides and uses thereof
|
CA2805902A1
(en)
|
2010-07-28 |
2012-02-02 |
Smartcells, Inc. |
Recombinant lectins, binding-site modified lectins and uses thereof
|
CA2805739A1
(en)
|
2010-07-28 |
2012-02-02 |
Smartcells, Inc. |
Drug-ligand conjugates, synthesis thereof, and intermediates thereto
|
CA2809321C
(en)
|
2010-08-30 |
2018-08-14 |
Sanofi-Aventis Deutschland Gmbh |
Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
|
BR112013010345A2
(pt)
|
2010-10-27 |
2017-07-25 |
Novo Nordisk As |
tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
|
AR083878A1
(es)
|
2010-11-15 |
2013-03-27 |
Boehringer Ingelheim Int |
Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
|
CN102188367B
(zh)
*
|
2011-01-05 |
2012-11-07 |
山东新时代药业有限公司 |
一种甘精胰岛素注射液及其制备方法
|
WO2012149106A1
(en)
|
2011-04-29 |
2012-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
US9993529B2
(en)
|
2011-06-17 |
2018-06-12 |
Halozyme, Inc. |
Stable formulations of a hyaluronan-degrading enzyme
|
US20130345113A1
(en)
*
|
2011-07-13 |
2013-12-26 |
Ronald E. Strohbehn |
Method of Use of Activated Functional Proteins to Improve Animal Health
|
EP2731947B1
(en)
|
2011-07-15 |
2019-01-16 |
Boehringer Ingelheim International GmbH |
Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
|
HUE027989T2
(en)
|
2011-08-29 |
2016-11-28 |
Sanofi Aventis Deutschland |
A pharmaceutical composition for use in glycemic control in patients with type 2 diabetes
|
AR087744A1
(es)
|
2011-09-01 |
2014-04-16 |
Sanofi Aventis Deutschland |
Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
|
EP2773331B1
(en)
*
|
2011-10-31 |
2016-02-10 |
Xeris Pharmaceuticals, Inc. |
Formulations for the treatment of diabetes
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
EP2849755A1
(en)
|
2012-05-14 |
2015-03-25 |
Boehringer Ingelheim International GmbH |
A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
US9555186B2
(en)
|
2012-06-05 |
2017-01-31 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
CA2890048C
(en)
|
2012-12-03 |
2022-05-03 |
Merck Sharp & Dohme Corp. |
O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
|
CA2889165A1
(en)
*
|
2012-12-19 |
2014-06-26 |
Wockhardt Limited |
A stable aqueous composition comprising human insulin or an analogue or derivative thereof
|
JP2016505601A
(ja)
*
|
2012-12-26 |
2016-02-25 |
ウォックハート リミテッド |
医薬組成物
|
TWI780236B
(zh)
*
|
2013-02-04 |
2022-10-11 |
法商賽諾菲公司 |
胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
|
US10201656B2
(en)
|
2013-03-13 |
2019-02-12 |
Tandem Diabetes Care, Inc. |
Simplified insulin pump for type II diabetics
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
US9670162B2
(en)
|
2013-03-14 |
2017-06-06 |
The Board Of Trustees Of The Leland Stanford Junio |
Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof
|
US9492608B2
(en)
|
2013-03-15 |
2016-11-15 |
Tandem Diabetes Care, Inc. |
Method and device utilizing insulin delivery protocols
|
WO2014161837A1
(en)
|
2013-04-03 |
2014-10-09 |
Sanofi |
Treatment of diabetes mellitus by long–acting formulations of insulins
|
WO2014177623A1
(en)
|
2013-04-30 |
2014-11-06 |
Novo Nordisk A/S |
Novel administration regime
|
WO2015008169A2
(en)
*
|
2013-07-04 |
2015-01-22 |
Insuline Medical Ltd. |
Device, system and method for delivery of a long-acting drug
|
AU2014329567B2
(en)
|
2013-10-04 |
2019-07-25 |
Merck Sharp & Dohme Corp. |
Glucose-responsive insulin conjugates
|
TW201605489A
(zh)
|
2013-10-25 |
2016-02-16 |
賽諾菲公司 |
賴谷胰島素(insulin glulisine)的穩定調配物
|
AU2015205620A1
(en)
*
|
2014-01-09 |
2016-07-14 |
Sanofi |
Stabilized pharmaceutical formulations of insulin aspart
|
WO2015104314A1
(en)
|
2014-01-09 |
2015-07-16 |
Sanofi |
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
|
AU2015205621A1
(en)
|
2014-01-09 |
2016-07-14 |
Sanofi |
Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
|
CN106102763A
(zh)
*
|
2014-01-13 |
2016-11-09 |
塞尔玛琳糖尿病有限责任公司 |
速效胰岛素制剂和药物递送***
|
EP3110449B1
(en)
|
2014-02-28 |
2023-06-28 |
Boehringer Ingelheim International GmbH |
Medical use of a dpp-4 inhibitor
|
SI3229828T1
(sl)
|
2014-12-12 |
2023-06-30 |
Sanofi-Aventis Deutschland Gmbh |
Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
CN105535942B
(zh)
*
|
2016-01-28 |
2017-07-28 |
通化东宝药业股份有限公司 |
一种赖脯胰岛素硫酸鱼精蛋白制剂的制备方法及其制备的赖脯胰岛素硫酸鱼精蛋白制剂
|
EP3419649A1
(en)
*
|
2016-02-25 |
2019-01-02 |
Wockhardt Limited |
Pharmaceutical composition of insulin glargine and amino acids
|
BR112018072401A2
(pt)
|
2016-06-10 |
2019-02-19 |
Boehringer Ingelheim International Gmbh |
combinações de linagliptina e metformina
|
AU2017378102B2
(en)
|
2016-12-16 |
2022-10-13 |
Novo Nordisk A/S |
Insulin containing pharmaceutical compositions
|
EP3624846A1
(en)
|
2017-05-16 |
2020-03-25 |
Bhami's Research Laboratory, Pvt. Ltd. |
High concentration protein formulations with reduced viscosity
|
TWI762706B
(zh)
|
2017-08-24 |
2022-05-01 |
丹麥商諾佛 儂迪克股份有限公司 |
Glp-1組成物及其用途
|
EP3740212A4
(en)
|
2017-12-18 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
CONJUGATE-BASED SYSTEMS FOR CONTROLLED INSULIN DELIVERY
|
WO2019125878A1
(en)
|
2017-12-18 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Conjugate based systems for controlled insulin delivery
|
US10335464B1
(en)
|
2018-06-26 |
2019-07-02 |
Novo Nordisk A/S |
Device for titrating basal insulin
|
CN110063932A
(zh)
*
|
2019-04-12 |
2019-07-30 |
浙江大学 |
一种多肽蛋白类药物的缓释组合物制剂及其制备方法
|
IL294520A
(en)
|
2020-02-18 |
2022-09-01 |
Novo Nordisk As |
Pharmaceutical formulations
|
CA3173417A1
(en)
|
2020-03-31 |
2021-10-07 |
Alborz Mahdavi |
Conjugates for selective responsiveness to vicinal diols
|
KR20230110505A
(ko)
|
2020-11-19 |
2023-07-24 |
프로토머 테크놀로지스 인크. |
방향족 붕소-함유 화합물 및 인슐린 유사체
|
WO2023017537A1
(en)
|
2021-08-12 |
2023-02-16 |
Celagenex Research (India) Pvt. Ltd. |
Oral algal oil based gastro-intestinal tract permeable peptide composition
|
WO2023225534A1
(en)
|
2022-05-18 |
2023-11-23 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and related insulin analogs
|